Creating solutions, not products, in diabetes

Roche Diabetes Care’s Michael Goetzl explains how the company is spearheading a combined digital-pharmaceutical approach to diabetes and how pharma firms can best embrace holistic strategie

Roche trumpets data for Soliris rival in NMOSD after US, EU ...

Drugs firms make massive discounts to get reimbursement in C...

Roche and Novartis are among the pharmaceuticals companies who have agreed to cut prices of some of their newest drugs by 61% on average to get them reimbursed in China, according to a repo

FDA cues up May verdict for Roche’s SMA challenger risdiplam

Takeda sets sights on first-line lung cancer market with new...

Investors look ahead to 2020 following briefings from pharma...

The great and the good of pharma and biotech descended on London to give investors updates on how their businesses are progressing at this year’s Jefferies conference, and provided insights